Researcher biography

Dr. Giorgia Mori is a Molecular Microbiologist passionate about finding solutions that help address the global health emergency posed by tuberculosis (TB). Her work focuses on the characterization of new TB drug leads, in order to overcome the major limitations associated with the currently available TB treatments. She received her PhD in 2014 from the University of Pavia (UNIPV, Italy) and she has 5 years of postdoctoral experience in academic research and 8 months experience in an industry position, working as a Bioinformatician at the European Institute of Oncology (IEO, Italy).

In 2019, she relocated from Italy to Australia, to take up the opportunity to drive the pre-clinical characterization of a highly promising novel TB drug lead in an internationally funded program at the University of Queensland (UQ, A/Prof. Antje Blumenthal's lab) that brings together a multi-disciplinary international team of microbiologists, immunologists and chemists.